Minerva Property Plant And Equipment Gross from 2010 to 2024
| NERV Stock | USD 2.50 0.04 1.63% |
Property Plant And Equipment Gross | First Reported 2013-12-31 | Previous Quarter 13.6 K | Current Value 12.2 K | Quarterly Volatility 109.4 K |
Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.5 K, Interest Expense of 8.7 M or Selling General Administrative of 10.9 B, as well as many exotic indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.
Minerva | Property Plant And Equipment Gross |
Latest Minerva Neurosciences' Property Plant And Equipment Gross Growth Pattern
Below is the plot of the Property Plant And Equipment Gross of Minerva Neurosciences over the last few years. It is Minerva Neurosciences' Property Plant And Equipment Gross historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Minerva Neurosciences' overall financial position and show how it may be relating to other accounts over time.
| Property Plant And Equipment Gross | 10 Years Trend |
|
Property Plant And Equipment Gross |
| Timeline |
Minerva Property Plant And Equipment Gross Regression Statistics
| Arithmetic Mean | 40,620 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 174.37 | |
| Mean Deviation | 41,555 | |
| Median | 17,836 | |
| Standard Deviation | 70,829 | |
| Sample Variance | 5B | |
| Range | 278K | |
| R-Value | 0.21 | |
| Mean Square Error | 5.2B | |
| R-Squared | 0.05 | |
| Significance | 0.44 | |
| Slope | 3,395 | |
| Total Sum of Squares | 70.2B |
Minerva Property Plant And Equipment Gross History
About Minerva Neurosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Minerva Neurosciences income statement, its balance sheet, and the statement of cash flows. Minerva Neurosciences investors use historical funamental indicators, such as Minerva Neurosciences's Property Plant And Equipment Gross, to determine how well the company is positioned to perform in the future. Although Minerva Neurosciences investors may use each financial statement separately, they are all related. The changes in Minerva Neurosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Minerva Neurosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Minerva Neurosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Property Plant And Equipment Gross | 18.8 K | 17.8 K |
Pair Trading with Minerva Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Minerva Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Minerva Stock
| 0.65 | VKTX | Viking Therapeutics | PairCorr |
| 0.54 | ELEV | Elevation Oncology | PairCorr |
| 0.49 | ERNA | Eterna Therapeutics | PairCorr |
| 0.46 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.41 | CGC | Canopy Growth Corp Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Minerva Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Minerva Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Minerva Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Minerva Neurosciences to buy it.
The correlation of Minerva Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Minerva Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Minerva Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Minerva Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Minerva Neurosciences Correlation against competitors. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Return On Assets (0.30) | Return On Equity (6.75) |
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.